Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heterologous Sequential mRNA Vaccination of Indian Rhesus Macaques Elicits Broad Binding and Neutralizing Antibody Responses Against Diverse Henipaviruses.

Viruses·2026
Same author

Prophylactic and therapeutic neutralizing monoclonal antibody treatment prevents lethal yellow fever infection.

JCI insight·2025
Same author

Acute-phase innate immune responses in SIVmac239-infected <i>Mamu-B*08+</i> Indian rhesus macaques may contribute to the establishment of elite control.

Frontiers in immunology·2024
Same author

Homotypic antibodies target novel E glycoprotein domains after natural DENV 3 infection/vaccination.

Cell host & microbe·2023
Same author

Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection.

Science translational medicine·2023
Same author

Molecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virus.

Nature communications·2022

Related Experiment Video

Updated: May 21, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Update on progress in HIV vaccine development.

David I Watkins1

  • 1University of Miami Miller School of Medicine, FL, USA.

Topics in Antiviral Medicine
|June 20, 2012
PubMed
Summary

New potent, broadly neutralizing antibodies offer hope for an HIV vaccine. Challenges remain in inducing these antibodies, but follicular helper T cells and cellular immune responses are key areas for future research.

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Diseases

Background:

  • Recent advancements in identifying potent, broadly neutralizing antibodies against HIV offer significant hope for vaccine development.
  • Inducing these highly effective antibodies through vaccination presents substantial challenges due to the extensive somatic mutations required.

Purpose of the Study:

  • To explore the potential of antibody-based vaccines for HIV prevention.
  • To discuss the role of follicular helper T cells and cellular immune responses in antibody induction.
  • To review findings from the Thai Phase III Vaccine Trial (RV144) regarding antibody roles in protection.

Main Methods:

  • Review of findings presented at the 19th Conference on Retroviruses and Opportunistic Infections.
  • Analysis of data suggesting the involvement of follicular helper T cells in antibody development.

More Related Videos

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

Related Experiment Videos

Last Updated: May 21, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

  • Examination of evidence correlating cellular immune responses with vaccine-induced protection.
  • Update on the Thai Phase III Vaccine Trial (RV144) data.

    • Main Results:

    • Identification of potent, broadly neutralizing antibodies against HIV.
    • Recognition of challenges in vaccine-induced antibody maturation.
    • Hypothesized involvement of follicular helper T cells in antibody development.
    • Correlation between vaccine-induced helper and killer T cells and protection from an attenuated vaccine.
    • Data suggesting a potential role for binding antibodies in HIV protection from RV144 trial.

    Conclusions:

    • Despite obstacles, the discovery of potent neutralizing antibodies fuels optimism for future HIV vaccine strategies.
    • Follicular helper T cells and cellular immune responses are critical components for effective HIV vaccine design.
    • The RV144 trial provides insights into the potential contribution of binding antibodies to HIV protection.